Robert J. Zollars

Former President-Dietary Products at Kraft General Foods Corp.

Robert J. Zollars

Robert J. Zollars

Former President-Dietary Products at Kraft General Foods Corp.

Overview
Career Highlights

Cardinal Health, Inc.
Baxter HealthCare Corporation
Scientific Products & Systems, Inc.

RelSci Relationships

3342

Number of Boards

21

Birthday

1958

Age

61

Relationships
RelSci Relationships are individuals Robert J. Zollars likely has professional access to. A relationship does not necessarily indicate a personal connection.

Executive Chairman at Five9, Inc.

Relationship likelihood: Strong

Former Chief Financial Officer at Unisys Corp.

Relationship likelihood: Strong

Co-Founder at Fundación Natividad de los Andes

Relationship likelihood: Strong

Chief Medical Officer at Vocera Communications, Inc.

Relationship likelihood: Strong

Former President, Chief Executive Officer, Director at VWR International, LLC

Relationship likelihood: Strong

President at Rutgers University

Relationship likelihood: Strong

Fund Advisor at Stephens Investment Management LLC

Relationship likelihood: Strong

Chairman of the Board, President & Chief Executive Officer at Vocera Communications, Inc.

Relationship likelihood: Strong

Former Operating Partner at Frazier Management LLC

Relationship likelihood: Strong

Operating Partner at Clayton Dubilier & Rice LLC

Relationship likelihood: Strong

Paths to Robert J. Zollars
Potential Connections via
Relationship Science
You
Robert J. Zollars
Former President-Dietary Products at Kraft General Foods Corp.
Education
B.S.In Marketing, magna cum laude

Arizona State University (commonly referred to as ASU or Arizona State) is a national space-grant institution and public metropolitan research university located in the Phoenix Metropolitan Area of Arizona. ASU is the largest public university in the United States by enrollment. Founded in 1885 as the Tempe Normal School for the Arizona Territory, the school came under control of the Arizona Board of Regents in 1945 and was renamed Arizona State College. A 1958 statewide ballot measure gave the university its present name, making Arizona State one of the nation's newest public research universities.

M.B.A. in Finance

OUR MISSION IS TO PROVIDE ACCESS TO HIGH-QUALITY, INNOVATIVE EDUCATIONAL OPPORTUNITIES THAT INTEGRATE THEORY AND LIFE EXPERIENCE. WE INSPIRE PERSONAL, PROFESSIONAL AND ACADEMIC GROWTH, AND ADVANCE THE WELL-BEING OF OUR DIVERSE LOCAL AND GLOBAL COMMUNITIES. THIS MISSION IS BUILT UPON OUR CORE VALUES.

Career History
President-Dietary Products
Tenure Unconfirmed

General Foods Corporation was a company whose direct predecessor was established in the USA by Charles William Post as the Postum Cereal Company in 1895. The name General Foods was adopted in 1929, after several corporate acquisitions. In November 1985, General Foods was acquired by Philip Morris Companies (now Altria Group, Inc.) for $5.6 billion, the largest non-oil acquisition to that time. In December 1988, Philip Morris acquired Kraft, Inc., and, in 1990, combined the two food companies as Kraft General Foods (KGF). "General Foods" was dropped from the corporate name in 1995 and now exists only as part of a y in Battle Creek, Michigan, having lived there since 1891, when he was a patient at a holistic sanitarium operated by Dr. John Harvey Kellogg.

Operating Partner
2015 - 2017

Frazier Management provides venture capital to invests in developing and commercializing novel therapeutics and and growth equity capital invests in healthcare services, pharmaceutical services, medical products, and related sectors. with primary focus on The firm invests across all stages of development.The firm's venture capital strategy focuses on all stages of biopharmaceutical and medical device companies including seed, early, mid, late, PIPEs and public. Their biopharmaceutical investment strategy focuses on companies that are developing novel therapeutics. They seek to identify early-stage companies that can use the firm's capital to move their products through clinical trials to achieve clinical proof of concept. Frazier works with a variety of types of companies including concept-stage, preclinical drug leads, clinical candidates and marketed products. The therapeutic modality also varies from small molecule to biologic. Frazier's medical device strategy focuses on companies with innovative technologies that address significant unmet clinical needs in large market segments.When considering a venture capital investment, Frazier looks for companies with exceptional management teams and capital efficient business models. They seek companies that are building their product portfolio through (1) novel targets or device-based approaches to existing targets which are significantly differentiated (2) paradigm-shifting therapeutic or device platforms to develop multiple products or (3) repositioning or in-licensing of existing drugs which are known to be safe and may have applications in other indications. The firm prefers to invest in products with large addressable markets in therapeutic areas that are supported by healthcare professionals who are open to innovative therapies. Frazier looks for therapeutic drug products that are close to or already in the clinic. They seek medical devices with moderate development risk that can rapidly generate clinical proof of principle and/or can be launched commercially within a reasonable time frame. Companies should have a clear path to regulatory approval and positive reimbursement decisions.Frazier also seeks to invest in cash-generating, growth-oriented healthcare companies. Types of investments include: acquisitions, recapitalizations, buyouts, build-ups and growth capital. They focus on the healthcare services, medical devices and supplies, specialty pharmaceutical and information technology-enabled services sectors. Investments typically range from $15 million to $50 million. The firm looks for companies with experienced management teams, attractive free cash flow margins, meaningful organic growth with the potential for consolidation opportunities, leading and defensible market positions, a predictable reimbursement environment and demonstrable customer loyalty.

Chief Executive Officer
2007 - 2018

Vocera is a leading provider of mobile communication solutions focused on addressing the most critical communication challenges facing hospitals today. We help our customers improve patient safety and satisfaction, and increase hospital efficiency and productivity with our Voice Communication solution and new Secure Messaging and Care Transition solutions. The Joint Commission data base on sentinel events identifies communication issues as one of the root causes in 82% of the reported occurrences in 2010. Additionally, a study published in the Journal of Healthcare Management conducted by Agarwal et. al.,"Quantifying the Economic Impact of Communication Inefficiencies in U.S. Hospitals" found that inefficient communication costs U.S. hospitals more than $12 billion annually or better than $4 million for a 500-bed hospital. More than 800 hospitals and healthcare facilities leverage Vocera solutions to achieve improved clinical, operational, and financial outcomes. The Vocera Voice Communication solution and the Vocera Care Transition solution are exclusively endorsed by the American Hospital Association.

Boards & Committees
Member, Nominating & Governance Committee
2004 - Current

VWR Funding, Inc. engages in the supply and distribution of laboratory equipment. The firm's products include chemicals, glassware, equipment, instruments, protective clothing, production supplies and other assorted laboratory products. It also provides certain services to some of its customers including technical services, on-site storeroom services and laboratory and furniture design, supply and installation. The company was founded in 1852 and is headquartered in Radnor, PA.

Director
Prior

Wound Care Solutions LLC supplies medical equipment. It offers surgical products in the United States. The company's clients include hospitals, clinics, and surgeons. Wound Care Solutions is headquartered in Jacksonville, FL.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1,000 - $4,999
2013

TO FIND A CURE FOR ALS, PROVIDE PATIENT AND FAMILY SUPPORT AND INCREASE PUBLIC AWARENESS.

$250 - $499
2007

TO FIND A CURE FOR ALS, PROVIDE PATIENT AND FAMILY SUPPORT AND INCREASE PUBLIC AWARENESS.

Political Donations
Transactions
Details Hidden

Vocera Communications, Inc. issued Common Stock

Details Hidden

Vocera Communications, Inc. raised money in a private placement transaction

Details Hidden

Global Healthcare Exchange LLC purchases Neoforma, Inc. from University Healthsystem Consortium, Inc., VHA, Inc.

Investments
Details Hidden

Five9, Inc. engages in the provision of cloud software for contact centers. It offers end-to-end solutions with omnichannel routing, analytics, WFO, and AI to increase agent productivity and deliver tangible business results. The company was founded in December 2001 and is headquartered in San Ramon, CA.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Robert J. Zollars. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Robert J. Zollars's profile does not indicate a business or promotional relationship of any kind between RelSci and Robert J. Zollars.